At non-toxic concentrations, the peptide effectively blocked membrane fusion mediated by the CCoV S glycoprotein and significantly reduced viral infection, as demonstrated both in cell-cell fusion assays and in live virus experiments. The gene discussed is ART4; the disease is viral infectious disease.